These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12700505)

  • 21. Comparison of stool enzyme immunoassay and immunochromatographic method for detecting Helicobacter pylori antigens before and after eradication.
    Wu DC; Wu IC; Wang SW; Lu CY; Ke HL; Yuan SS; Wang YY; Chang WH; Wang TE; Bair MJ; Kuo FC
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):373-8. PubMed ID: 17157673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.
    Kao AW; Cheng HC; Sheu BS; Lin CY; Sheu MJ; Yang HB; Wu JJ
    J Gen Intern Med; 2005 Feb; 20(2):139-42. PubMed ID: 15836546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
    Gisbert JP; Ducons J; Gomollón F; Domínguez-Muñoz JE; Borda F; Miño G; Jiménez I; Vázquez MA; Santolaria S; Gallego S; Iglesias J; Pastor G; Hervás A; Pajares JM
    Rev Esp Enferm Dig; 2003 Feb; 95(2):121-6, 115-20. PubMed ID: 12760719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
    Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
    Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Actual problems of helicobacteriosis diagnostics].
    Baryshnikova NV
    Eksp Klin Gastroenterol; 2009; (2):50-6. PubMed ID: 19554677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic methods for Helicobacter pylori infection in children].
    de Haan SN; Kindermann A; Dahhan N; Bosman DK
    Ned Tijdschr Geneeskd; 2005 Jun; 149(24):1326-9. PubMed ID: 16008035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Helicobacter pylori infection: what are the specific questions in childhood?].
    Gottrand F
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):484-7. PubMed ID: 12700507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
    Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Helicobacter pylori: invasive and non-invasive tests.
    Ricci C; Holton J; Vaira D
    Best Pract Res Clin Gastroenterol; 2007; 21(2):299-313. PubMed ID: 17382278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' attitudes to Helicobacter pylori breath and stool antigen tests compared to blood serology.
    McNulty CA; Whiting JW
    J Infect; 2007 Jul; 55(1):19-22. PubMed ID: 17276512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
    Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Ez-HBT Helicobacter blood test to establish Helicobacter pylori eradication.
    Ahmed F; Murthy UK; Chey WD; Toskes PP; Wagner DA
    Aliment Pharmacol Ther; 2005 Nov; 22(9):875-80. PubMed ID: 16225498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Helicobacter pylori infection.
    Meurer LN; Bower DJ
    Am Fam Physician; 2002 Apr; 65(7):1327-36. PubMed ID: 11996414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of Helicobacter pylori infection.
    Dzierzanowska-Fangrat K; Lehours P; Mégraud F; Dzierzanowska D
    Helicobacter; 2006 Oct; 11 Suppl 1():6-13. PubMed ID: 16925605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis.
    Lahner E; Vaira D; Figura N; Pilozzi E; Pasquali A; Severi C; Perna F; Delle Fave G; Annibale B
    Helicobacter; 2004 Oct; 9(5):436-42. PubMed ID: 15361083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
    Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.